Nicole Marie Psaltis, O.D. WJB Dorn VAMC, Columbia SC Residents Day Proposal August 30, 2010

Total Page:16

File Type:pdf, Size:1020Kb

Nicole Marie Psaltis, O.D. WJB Dorn VAMC, Columbia SC Residents Day Proposal August 30, 2010 Nicole Marie Psaltis, O.D. WJB Dorn VAMC, Columbia SC Residents Day Proposal August 30, 2010 • Abstract ‐ Retinitis pigmentosa (RP) is a group of inheritable eye conditions, constituting retinal and RPE dystrophies, which progress to vision loss. Patients with identical genetic mutations can manifest different phenotypic presentations. This case describes an atypical presentation of RP. • Case History ‐ A 57‐year‐old Caucasian male veteran presented to the Wm. Jennings Bryan Dorn VA Eye Cinic in Columbia, South Carolina on June 23, 2009 ‐ Chief Complaint Decreasing peripheral field of vision The patient had a secondary complaint of painless blurred vision distance and near of gradual onset ‐ Ocular History Hyperopic astigmatism OU Unremarkable ocular health history per patient’s account Last eye exam was 2.5 years ago ‐ Medical History Alcohol abuse Esophageal reflux Hypercholesterolemia Hypothyroidism Depression PTSD Substance Abuse ‐ Medications Citalopram Hydrobromide Hydrochlorothiazide Nicotine Patch Omeprazole Simvastatin Trazodone ‐ Allergies Naproxen ‐ Family Ocular History Unremarkable ‐ Pertinent Findings Entering VA: 20/25+2 OD, 20/25 OS cc Pupils: PERRL (‐) APD EOM: FROM OU CVF: Constricted OU Subjective Refraction: +2.00‐2.00x109 OD +2.25‐1.25x065 OS Anterior Segment Evaluation: WNL OU Tap: 13 mmHg OD, 14 mmHg OS @ 1109 AM DFE: Atrophic presentation with distinct cessation perifoveally OU. Coalesced hyperplastic lesions, rarely in bone spicule appearance, scattered throughout posterior pole OU. Scattered areas of atrophy of scalloped appearance in far periphery to ora serrata. Vessels are mildly narrow and attenuated OU. Maculae were flat and intact OU. The optic nerve cup‐to‐disc ratios are 0.10, round OU. The presentation is symmetrical. Diagnosis: Unspecified Bilateral Annular Chorioretinal Atrophy ‐ September 4, 2009 Follow‐up The patient now presents with a secondary complaint of distorted central vision as if he is “looking through a screen door”. He also complains of photopsias and chromatopsias yellow and blue in color When probed, the patient reports his grandfather having an unexplained loss of peripheral vision. BCVA: 20/25+2 OD, 20/25 OS cc DFE: Cotton wool spot along superior‐temporal vascular arcade OD Atrophic and pigmentary retinal presentation appears stable from 6/23/2009. Plan: Request fee‐basis ERG; refer to ophthalmology for further retinal evaluation • Laboratory Studies: ‐ On September 4, 2009 a Humphrey Visual Field 30‐2 was attempted, however the patient was unable to complete the field due to excessive jaw movement secondary to denture plates. When probed regarding the HVF, the patient reported he was unable to “see peripheral lights”. ‐ Macular OCT September 4, 2009 OD: Foveal thickness 157 microns; radial analysis displays slight retinal elevation OS: Foveal thickeness 191 microns; radial analysis displays slight retinal elevation ‐ Full‐Field ERG November 9, 2009 Significant loss of rod function OU and borderline abnormality of cone function OU ‐ Goldmann Perimetry‐ pending Expect ring scotoma OU ‐ Serum ornithine WNL • Differential Diagnoses ‐ Retinitis Pigmentosa ‐ Gyrate Atrophy However, patient’s plasma ornithine level normal ‐ Infectious processes Syphilis, Toxoplasmosis FTA‐ABS, serum IgG normal ‐ Paraneoplastic Retinopathy ‐ Cone‐Rod Dystrophy ‐ Drug Toxicity • Diagnosis and Discussion: ‐ Retinitis Pigmentosa Retinitis Pigmentosa (RP) is a group of interited retinal dystrophies differentiated by abnormalitiy of the photoreceptors and retinal pigment desposits detected by fundoscopy. Pigment deposits are predominant in the retinal periphery and the central retina is usually spared. The most common form is known as rod‐cone dystrophy, with night blindness as the primary symptom and progressing to peripheral vision loss under photopic conditions. The rods primarily degenerate while there is a secondary degeneration of cones. Cases have been known to progress rapidly over a few decades while others never result in blindness. Some cases present as a cone‐rod dystrophy and visual acuity loss dominates over peripheral vision loss. There are non‐syndromic and syndromic forms. As of 2006, 45 causative loci have been identified in the non‐syndromic form. Molecular diagnosis is difficult due to the mass heterogeneity of the disorder. There is a family history in approximately 50% of cases. Typically, the earliest symptom of RP is nyctalopia (difficulty seeing under low light conditions) followed by photophobia and decreased visual acuity in later stages. Patchy mid peripheral field loss eventually evolves to form a ring scotoma and tunnel vision. Bone spicule deposits, attenuation of retinal vessels, retinal atrophy and waxy disc pallor are typical RP fundus findings. The ERG generally shows dramatic weakening of a‐wave and b‐wave amplitudes. The traditional form of RP is divided into three stages. In the first stage, nyctalopia is the initial symptom and generally becomes apparent in the second decade of life. In this stage, peripheral visual field defects tend to only occur in dim light. The fundus appearance may be normal. The ERG is the key to diagnosis during this early stage, as there will be a decreased b‐wave under scotopic conditions. In the mid stage, nyctalopia is obvious and the patient is aware of peripheral vision loss under all lighting conditions. Patients also become photophobic on account of macular disruption due to mild atrophy or edema, however the foveomacular area and far periphery remain relatively spared. There is vessel attenuation and disc pallor. In the end stage, patients reach tunnel vision and are not able to get around autonomously. Pigment is now deposited in the foveomacular area. RP is further categorized into early and late onset. Early onset is diagnosed when symptoms of mid stage RP is present at two years of age. Late onset is diagnosed when early stage begins around mid life. Autosomal dominant forms are generally the mildest forms, and in some cases may start after age 50. Autosomal recessive forms typically begin in the first decade of life. X‐linked RP also tends to start early and is associated with myopia. When there is rapid progression of symptoms later in life, ocular trauma, inflammation, infection, paraneoplastic syndromes and a spinocerebellar ataxia should be considered. The patient under investigation has no history of ocular trauma or signs of inflammation. CBC does not show any signs of underlying infection and there is no evidence of malignancy. Spinocerebellar ataxia is unlikely as patient’s gait and coordination are normal. This case represents a unique presentation of what is likely RP. There is an annular chorioretinal atrophy which begins in the mid‐periphery and spares the foveomacular region. The pigment deposits are rarely of bone spicule formation and have the appearance of larger pigment clumps. The scalloped margins of atrophy resemble that consistent in gyrate atrophy, however, the patient’s ornithine levels are normal. The presentation is symmetrical. The patient has a chronic subtle macular edema, verified by OCT. FANG is still pending. Although the patient was unsure of details of his family’s ocular history, he did report his grandfather suffering from an unknown loss of peripheral vision. The patient’s retinal vascular was only minimally attenuated and optic discs did not have a pallor appearance. Bass et al described a family with a hereditary retinal disease consisting of retinal and choroidal atrophy with spared maculae and preserved visual acuity. While some of the family members were symptomatic with loss of visual field, others were asymptomatic and none reported nyctalopia. FANG on these patients revealed hyperfluorescence in areas of retinal atrophy and hypofluorescence in areas pertaining to choroidal atrophy. Although FANG has not yet been performed by the patient of interest, the fundus presentation is similar to those described by Bass et al, however the Bass et al patients did not experience nyctalopia and rods were spared on account of their normal ERGs. Interestingly, further genetic testing revealed the Thr17Met variant, a rhodopsin mutation associated with autosomal dominant RP. • Treatment/Management ‐ There is no current therapy which can completely cease the progression of pigmentary retinopathies or will restore the loss of vision. The current management involves decelerating the degeneration, treating secondary complications, and helping the patient cope with blindness. Vitamins A and E have been shown to protect photoreceptors with trophic and anti‐oxidant effects. However, there is no conclusive evidence of the benefits of Vitamin A. Vitamin A has not yet been prescribed for this patient. If Vitamin A is prescribed, serum retinol, triglycerides and liver enzymes should be monitored regularly. Due to the clinical evidence that many forms of genetic pigmentary retinopathies are light‐ dependent, patients should be instructed to wear UV protection when outdoors. Yellow‐ orange shades reduce photophobia, a common symptom of RP. Sunglass recommendation was made to this patient. The most frequent complications of RP include posterior subcapsular cataracts and macular edema. The patient of interest has visually insignificant nuclear sclerosis of the lens OU, but not the characteristic posterior capsular opacity of RP. A central posterior subcapsular cataract will blur the remaining central vision of an RP patient, and on account must be removed even though
Recommended publications
  • Masqueraders of Age-Related Macular Degeneration
    COVER STORY Masqueraders of Age-related Macular Degeneration A number of inherited retinal diseases phenocopy AMD. BY RONY GELMAN, MD, MS; AND STEPHEN H. TSANG, MD, PHD ge-related macular degeneration (AMD) is a leading cause of central visual loss among the elderly population in the developed world. The Currently, there are no published A non-neovascular form is characterized by mac- guidelines to prognosticate ular drusen and other abnormalities of the retinal pigment epithelium (RPE) such as geographic atrophy (GA) and Stargardt macular degeneration. hyperpigmented areas in the macula. The neovascular form is heralded by choroidal neovascularization (CNV), with subsequent development of disciform scarring. ABCA4 defect heterozygote carrier may be as high as This article reviews the pathologic and diagnostic char- one in 20.11,12 An estimated 600 disease-causing muta- acteristics of inherited diseases that may masquerade as tions in the ABCA4 gene exist, of which the three most AMD. The review is organized by the following patterns common mutations account for less than 10% of the of inheritance: autosomal recessive (Stargardt disease and disease phenotypes.13 cone dystrophy); autosomal dominant (cone dystrophy, The underlying pathology of disease in STGD involves adult vitelliform dystrophy, pattern dystrophy, North accumulation of lipofuscin in the RPE through a process Carolina macular dystrophy, Doyne honeycomb dystro- of disc shedding and phagocytosis.14,15 Lipofuscin is toxic phy, and Sorsby macular dystrophy); X-linked (X-linked to the RPE; furthermore, A2E, a component of lipofuscin, retinoschisis); and mitochondrial (maternally inherited causes inhibition of 11-cis retinal regeneration16 and diabetes and deafness). complement activation.
    [Show full text]
  • Genetic Defects of CHM and Visual Acuity Outcome in 24 Choroideremia
    www.nature.com/scientificreports OPEN Genetic defects of CHM and visual acuity outcome in 24 choroideremia patients from 16 Japanese families Takaaki Hayashi1,2*, Shuhei Kameya3, Kei Mizobuchi2, Daiki Kubota3, Sachiko Kikuchi3, Kazutoshi Yoshitake4, Atsushi Mizota5, Akira Murakami6, Takeshi Iwata4 & Tadashi Nakano2 Choroideremia (CHM) is an incurable progressive chorioretinal dystrophy. Little is known about the natural disease course of visual acuity in the Japanese population. We aimed to investigate the genetic spectrum of the CHM gene and visual acuity outcomes in 24 CHM patients from 16 Japanese families. We measured decimal best-corrected visual acuity (BCVA) at presentation and follow-up, converted to logMAR units for statistical analysis. Sanger and/or whole-exome sequencing were performed to identify pathogenic CHM variants/deletions. The median age at presentation was 37.0 years (range, 5–76 years). The mean follow-up interval was 8.2 years. BCVA of the better-seeing eye at presentation was signifcantly worsened with increasing age (r = 0.515, p < 0.01), with a high rate of BCVA decline in patients > 40 years old. A Kaplan–Meier survival curve suggested that a BCVA of Snellen equivalent 20/40 at follow-up remains until the ffties. Fourteen pathogenic variants, 6 of which were novel [c.49 + 5G > A, c.116 + 5G > A, p.(Gly176Glu, Glu177Ter), p.Tyr531Ter, an exon 2 deletion, and a 5.0-Mb deletion], were identifed in 15 families. No variant was found in one family only. Our BCVA outcome data are useful for predicting visual prognosis and determining the timing of intervention in Japanese patients with CHM variants.
    [Show full text]
  • Role of Intuitive Knowledge in the Diagnostic Reasoning of Hospital Specialists: a Focus Group Study
    Open access Research BMJ Open: first published as 10.1136/bmjopen-2018-022724 on 28 January 2019. Downloaded from Role of intuitive knowledge in the diagnostic reasoning of hospital specialists: a focus group study Nydia Van den Brink,1 Birgit Holbrechts,1 Paul L P Brand,2 Erik C F Stolper,1,3 Paul Van Royen3 To cite: Van den Brink N, ABSTRACT Strengths and limitations of this study Holbrechts B, Brand PLP, et al. Background and objective Intuition is an important part Role of intuitive knowledge of human decision-making and can be explained by the ► This is the first study exploring the role of intuition in in the diagnostic reasoning dual-process theory where analytical and non-analytical of hospital specialists: a hospital specialists’ diagnostic reasoning. reasoning processes continually interact. These processes focus group study. BMJ Open ► The study was performed in two European countries. can also be identified in physicians’ diagnostic reasoning. 2019;9:e022724. doi:10.1136/ ► The used qualitative approach enabled the re- The valuable role of intuition, including gut feelings, has bmjopen-2018-022724 searchers to study the views of specialists on the been shown among general practitioners and nurses, but topic and the meanings they attach to the concept. ► Prepublication history for less is known about its role among hospital specialists. ► It was not the aim of the researchers to gather data this paper is available online. This study focused on the diagnostic reasoning of hospital To view these files, please visit for the calculation of predictive values of intuitive specialists, how they value, experience and use intuition.
    [Show full text]
  • Retinitis Pigmentosa Precision Panel Overview Indications Clinical
    Retinitis Pigmentosa Precision Panel Overview Retinitis Pigmentosa (RP) comprises a complex group of inherited dystrophies characterized by degeneration and dysfunction of the retina, affecting photoreceptor and pigment epithelial function. RP can be an isolated finding or be part of a syndrome that can be inherited in a dominant, recessive or X-linked pattern. This disease presents as progressive loss of night and peripheral vision, leading to a constricted visual field and markedly diminished vision. The clinical presentation of these findings is highly variable, some patients being affected during childhood while others are asymptomatic well into adulthood. There is an increase in mortality rate due to psychiatric comorbidities. The Igenomix Retinitis Pigmentosa Precision Panel can be used to make an accurate and directed diagnosis as well as a differential diagnosis of blindness ultimately leading to a better management and prognosis of the disease. It provides a comprehensive analysis of the genes involved in this disease using next-generation sequencing (NGS) to fully understand the spectrum of relevant genes involved. Indications The Igenomix Retinitis Pigmentosa Precision Panel is indicated for those patients with a clinical suspicion or diagnosis with or without the following manifestations: - Family history of RP - Night blindness - Progressive constriction of the visual field, usually peripheral - Cataracts - Sensation of sparking lights (photopsias) - Headache Clinical Utility The clinical utility of this panel is: - The genetic and molecular confirmation for an accurate clinical diagnosis of a symptomatic patient. - Early initiation of multidisciplinary treatment in the form of medical care with vitamin A and other antioxidants and surgical care for potential cataract extraction or retinal prosthesis.
    [Show full text]
  • New Media for New Organs: a Virtual Community For
    462-469 CON342344 Bers_CON 170x242mm 06/10/2009 16:29 Page 462 Convergence: The International Journal of Research into New Media Technologies Copyright © The Author(s), 2009. Reprints and permissions http://www.sagepub.co.uk/journalsPermissions.nav FEATURE REPORT London, Los Angeles, New Delhi, Singapore, and Washington DC Vol 15(4): 462–469 DOI: 10.1177/1354856509342344 http://con.sagepub.com New Media for New Organs A Virtual Community for Pediatric Post-Transplant Patients Marina U. Bers Tufts University, USA Abstract / This article describes an eight-month pilot study in which 19 pediatric post-transplant patients at Children’s Hospital Boston, ages 11 to 15, used a computer-based psychosocial inter- vention developed on the Zora 3D multiuser environment. Zora provides tools to create an online virtual city and populate it with houses and personally-meaningful objects. Users can communicate with each other via real-time chat and participate in open-ended guided activities to create a social network of peers. Preliminary results support the idea that innovative technologies can help adoles- cent patients to create a support network of peers when face-to-face interactions are impossible. Key Words / children’s virtual community / health care / multi-user virtual environment / online games / real-time chat Introduction New media is having an impact in the way children learn, play and communicate. From video-games to virtual tutors, from I-pods to on-line shopping, today’s children are immersed in a culture in which computers and the internet are vastly used for most of their needs (Subrahmanyam et al., 2001). Most recently, these needs have also started to expand to health care.
    [Show full text]
  • Retinitis Pigmentosa: a Brief Review of the Genetic and Clinical Aspects
    Retinitis Pigmentosa: A Brief Review of the Genetic and Clinical Aspects of the Disease Itia Dowdell Science and Technology Honors Program, University of Alabama at Birmingham, Birmingham, AL, USA School of Health Professions Honors Program, University of Alabama at Birmingham, Birmingham, AL, USA Department of Clinical and Diagnostic Sciences, University of Alabama at Birmingham, Birmingham, AL, USA Abstract Retinitis Pigmentosa (RP) is a heterogeneous set of inherited retinal diseases that affects 1 in 3,000–7,000 people worldwide. Typical onset is from 10–30 years old and most forms are progressive, often leading to blindness. Defects in more than 200 genes have been identified that cause RP. The disease is characterized as a progressive rod-cone dystrophy that presents with night blindness, loss of peripheral vision, waxy pallor of the optic disc, pigmentary changes, and a reduced visual field. There are different modes of transmission of RP: autosomal dominant (ADRP), autosomal recessive (arRP), X-linked (XLRP) and mitochondrial. The genetics behind the different forms of RP and the degree of severity vary, although some overlap, thus contributing to the difficulty of differential diagnosis. RP can manifest either as a non-syndromic disease, or as part of a syndrome, such as in Usher’s syndrome (hearing and vision loss) and BardetBiedl syndrome (a ciliopathy). The purpose of this review is to summarize the major genetic and molecular findings, as well as the diseases, associated with RP. Due to space limitations, this review is not fully comprehensive. Keywords: Retinitis pigmentosa, non-syndromic retinitis pigmentosa, rod-cone dystrophy, rhodopsin Introduction Retinitis pigmentosa (RP) is a heterogeneous set of inherited retinal diseases.
    [Show full text]
  • Retinitis Pigmentosa and Allied Disorders Yog Raj Sharma, P
    JK SCIENCE REVIEW ARTICLE Retinitis Pigmentosa and Allied Disorders Yog Raj Sharma, P. Raja Rami Reddy, Deependra V. Singh Retinitis pigmentosa (RP) is a generic term for a group Visual field loss is insidious, progressive, peripheral of disorders characterized by hereditary diffuse usually and symmetric between two eyes (except x-linked RP bilaterally symmetrical progressive dysfunction, cell loss which can have bizarre and asymmetric patterns). In the and eventual atrophy of retina. Initially photoreceptors majority of patients the earliest defects are relative are involved and subsequently inner retina is damaged. scotomas in the periphery between 30 and 50 degrees Although both rods and cones are involved, damage to from fixation, which enlarge, deepen and coalesce to the rods is predominant. RP may be seen in isolation form a ring of visual field loss. As ring scotomas enlarge (Typical RP) or in association with systemic diseases. toward the far periphery, islands of relatively normal The reported prevalence of typical RP is approximately vision remain usually temporal but occasionally 1: 50000 worldwide. Most commonly 46% of the cases inferiorly. In typical RP the progression of visual loss is are sporadic with only one affected member in a given slow and relentless. Berson et al found that overall about family. X- linked recessive inheritance is least common, 4.6% of remaining visual field was lost per year (3). amounting to 8%. Autosomal dominant inheritance is Central visual loss found in 19% and recessive in 19%. The age of onset This can occur early in typical RP while significant and the natural history of the disease depend on the peripheral field remains cystoid macular edema, macular inheritance.
    [Show full text]
  • Stargardt Disease
    Stargardt disease Author: Professor August. F. Deutman1 Creation Date: January 2003 Scientific Editor: Professor Jean-Jacques De Laey 1Institute of Ophthalmology, University Hospital Nijmegen, Postbox 9101, 6500 HB Nijmegen, Netherlands. Abstract Keywords Disease name and synonyms Excluded diseases Definition Frequency Clinical description Management including treatment Etiology Diagnosis References Abstract Stargardt's disease is a form of juvenile hereditary macular degeneration characterized by discrete yellowish round or pisciform flecks around the macula at the level of the retinal pigment epithelium (rpe). Stargardt's disease is the most common hereditary macular dystrophy. Prevalence is estimated between 1 in 8,000 and 1 in 10,000. Disease onset occurs typically in the first or second decade of life and manifests as decreased visual acuity. In the early stages, the macula usually shows discrete rpe changes, followed later by an horizontal ovoid zone of beaten bronze atrophy. In final stages, the macula can be associated with central areolar choroidal dystrophy. Fluorescein angiography reveals the characteristic dark choroid (''silence choroidien''), which probably results from the accumulation of lipofuscin in the rpe. This disease has usually an autosomal recessive inheritance pattern but some dominant pedigrees have been reported. The autosomal type has been associated with mutations in the ABCR gene, which encodes a transmembrane transporter protein expressed by the rod outer segments. There is currently no treatment available for Stargardt's disease. Keywords Stargardt, Macula, Fundus flavimaculatus Disease name and synonyms Definition • Stargardt’s disease Stargardt’s disease (Stargardt, 1909, 1913, • Fundus flavimaculatus 1916, 1917, 1925; Weleber, 1994; Armstrong et al., 1998) is a form of juvenile hereditary macular Excluded diseases degeneration characterized by discrete yellowish • Cone dystrophy round or pisciform flecks around the macula at the level of the retinal pigment epithelium (rpe).
    [Show full text]
  • Please Fill out the Front and Back of This Medical History Form. Chart#: Name: Date: Family Physician: Referral Source: REVI
    Advanced Cataract Surgery • Lens Implants • LASIK Laser Vision Surgery • Glaucoma Surgery • Retina Laser Surgery • Contact Lens • Pediatric Eye Care • Eyelid Surgery Board-Certifie d Medical and Surgical Ophthalmologists Fellows of the American Academy of Ophthalmology Baptiste J. Dejean, III, M.D., F.A.C.S. Timothy W. Doucet, M.D. Craig C. Kuglen, Jr., M.D. Renee E. Williams, O.D. Linda H. Lin, M.D. P. Steven Black, O.D. Mark H. Wilkerson, M.D. Andrew W. Dvorak, M.D. Jonathan T. Jan, M.D. Please Fill Out the Front and Back of this Medical History Form. Chart#: Name: Date: Family Physician: Referral Source: REVIEW OF SYSTEMS: Are you currently experiencing any of the following symptoms? (Circle all that apply) Constitutional Eye Ear/Nose/Throat Cardiovascular Fever Blurry Congestion Chest Pain/Pressure Fatigue Foggy Sore Throat Racing Heart Poor Appetite Glare Hearing Trouble Ankle Swelling Night Sweats Blindness Ear Ringing Chills Tunnel Vision Nose Bleed Hoarseness Respiratory Short of Breath Gastrointestinal Genitourinary Musculoskeletal Cough Indigestion Difficult Urination Weakness Wheezing Nausea/Vomiting Frequent Urination Aches Diarrhea Burning Muscle Cramps Constipation Pain Skin/Breast Tarry/Bloody Stool Hives Rash Neurological Psychiatric Endocrine Sores Dizziness Confusion Weight Loss Lump Severe Headache Poor Memory Weight Gain Pain Neck Pain Depressed Poor Energy Back Pain Poor Sleep Heme/Lymph Numbness Nervous/Tense Bruising Nose Bleed Allergy/Immune Other: Lymph Nodes Sinus Sneezing Hay Fever Frequent Infections PAST MEDICAL HISTORY: Has the patient had any of the following conditions? (Circle all that apply) Cataracts Ulcer Heart Disease Paralysis Cancer (type): Glaucoma Jaundice Kidney Stone Drug Addiction High Blood Pressure Hay Fever Gallstone Bladder Trouble Prostate Trouble Tuberculosis Asthma Liver Disease Thyroid Disease Nerve Disease Anemia Diabetes Hepatitis Stroke Muscle Disease Bleeding Disorder Pneumonia Colitis Infections Seizure High Cholesterol (over) OTHER EYE OR MEDICAL PROBLEM: Eye/Medical Issue Date Eye/Medical Issue Date 1.
    [Show full text]
  • Colour Vision Deficiency
    Eye (2010) 24, 747–755 & 2010 Macmillan Publishers Limited All rights reserved 0950-222X/10 $32.00 www.nature.com/eye Colour vision MP Simunovic REVIEW deficiency Abstract effective "treatment" of colour vision deficiency: whilst it has been suggested that tinted lenses Colour vision deficiency is one of the could offer a means of enabling those with commonest disorders of vision and can be colour vision deficiency to make spectral divided into congenital and acquired forms. discriminations that would normally elude Congenital colour vision deficiency affects as them, clinical trials of such lenses have been many as 8% of males and 0.5% of femalesFthe largely disappointing. Recent developments in difference in prevalence reflects the fact that molecular genetics have enabled us to not only the commonest forms of congenital colour understand more completely the genetic basis of vision deficiency are inherited in an X-linked colour vision deficiency, they have opened the recessive manner. Until relatively recently, our possibility of gene therapy. The application of understanding of the pathophysiological basis gene therapy to animal models of colour vision of colour vision deficiency largely rested on deficiency has shown dramatic results; behavioural data; however, modern molecular furthermore, it has provided interesting insights genetic techniques have helped to elucidate its into the plasticity of the visual system with mechanisms. respect to extracting information about the The current management of congenital spectral composition of the visual scene. colour vision deficiency lies chiefly in appropriate counselling (including career counselling). Although visual aids may Materials and methods be of benefit to those with colour vision deficiency when performing certain tasks, the This article was prepared by performing a evidence suggests that they do not enable primary search of Pubmed for articles on wearers to obtain normal colour ‘colo(u)r vision deficiency’ and ‘colo(u)r discrimination.
    [Show full text]
  • Setting High Standards of Care for Low Vision
    Low Vision Treatment Setting High Standards of Care for Low Vision www.neoretina.com Thousands of Indians suer from low vision. Are you one among them? Low Vision is a condition of visual impairment that cannot be corrected through glasses, medicines or surgical treatments. The condition is often characterized by partial sight, blurred vision, tunnel vision or blind spots. Low vision impacts both adults and children but mostly occurs among adults above 60 years of age. Losing the ability to perform basic activities: drive, read, watch or view, etc. can make one feel shut o from living a normal life. What causes low vision? Generally, the low vision condition is caused by eye diseases or health conditions such as Age-related Macular Degeneration (AMD), Cataract, Diabetic Retinopathy, Retinitis Pigmentosa, Stargardt's Disease (juvenile Macular Degeneration) and Glaucoma. Eye injuries, congenital disabilities and brain damages are some other causes. The chances to restore eyesight due to low vision are unlikely, but it can be managed with proper devices and vision rehabilitation. How do you know if you have low vision? A person with low vision condition has poor eyesight, where he is unable to perform routine duties, despite regular glasses, medicine, and surgery. Commonly individuals with low vision can have diculty in: Reading and writing Using a Computer/Tablet or watching Reading trac signals, Television name boards, etc. Spotting switches, dials or other Recognizing familiar faces mechanical controls Neoretina: Comprehensive & Technologically Enhanced Centre for Low Vision Treatment Neoretina Eyecare Institute, Hyderabad oers world-class treatment in the management of the low vision and other eye conditions.
    [Show full text]
  • Retinitis Pigmentosa, Ataxia, and Peripheral Neuropathy
    J Neurol Neurosurg Psychiatry: first published as 10.1136/jnnp.46.3.206 on 1 March 1983. Downloaded from Journal of Neurology, Neurosurgery, and Psychiatry 1983;46:206-213 Retinitis pigmentosa, ataxia, and peripheral neuropathy RR TUCK, JG McLEOD From the Department ofMedicine, University ofSydney, Australia SUMMARY The clinical features of four patients with retinitis pigmentosa, ataxia and peripheral neuropathy but with no increase in serum phytanic acid are reported. Three patients also had sensorineural deafness and radiological evidence of cerebellar atrophy. Nerve conduction studies revealed abnormalities of sensory conduction and normal or only mild slowing of motor conduc- tion velocity. Sural nerve biopsy demonstrated a reduction in the density of myelinated fibres. There were no onion bulb formations. These cases clinically resemble Refsum's disease, but differ in having no detectable biochemical abnormality, and a peripheral neuropathy which is not hypertrophic in type. They may represent unusual cases of spinocerebellar degeneration. Retinitis pigmentosa occurs infrequently as an iso- (WAIS). He had a speech impediment but was not dysar- Protected by copyright. lated finding in otherwise healthy individuals and thric. He was of short stature, had a small head and pes families. Its association with deafness, with or with- cavus but no kyphoscoliosis. His visual acuity in the right eye was 6/60 while in the left he could count fingers only. out other neurological abnormalities is much less The right visual field was constricted but the left could not common but nevertheless well recognised.1 In be tested. The optic discs were pale, the retinal vessels heredopathia atactica polyneuritiformis (Refsum's small in diameter and throughout the retinae there was disease), abetalipoproteinaemia, and the Keams- scattered "bone corpuscle" pigmentation.
    [Show full text]